Evaluation of lipid metabolism in patients with chronic, active hepatitis (HBsAg positive)
Kryska, A.; Juszczyk, J.; Bereszyńska, I.; Krajewski, P.
Polski Tygodnik Lekarski 46(8-10): 159-160
1991
ISSN/ISBN: 0032-3756 PMID: 1845736 Document Number: 378574
Selected parameters of the lipid metabolism were evaluated in patients with HBsAg-positive chronic, active hepatitis. A decrease in alpha-lipoproteins and an increase in plasma biliary acids level were found.
Document emailed within 1 workday
Related Documents
Goudeau, A.; Lo, K.J.; Coursaget, P.; Tong, M.J.; Yeh, C.L.; Tsai, Y.T.; Lee, J.K.; Wu, T.C.; Yeh, S.H.; Lee, S.D. 1983: Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization Developments in Biological Standardization 54: 399-404Juszczyk, J. 1984: Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa) Polski Tygodnik Lekarski 39(33): 1085-1089
Lukhwareni, A.; Burnett, R.J.; Selabe, S.G.; Mzileni, M.O.; Mphahlele, M.J. 2009: Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital Journal of Medical Virology 81(3): 406-412
Thomas, H.C.; Potter, B.J.; Elias, E.; Sherlock, S. 1979: Metabolism of the third component of complement in acute type B hepatitis, HBs antigen positive glomerulonephritis, polyarteritis nodosum, and HBs antigen positive and negative chronic active liver disease Gastroenterology 76(4): 673-679
Chuang, W.L.; Chang, W.Y.; Wang, L.Y.; Tsai, J.F.; Hsieh, M.Y.; Chen, S.C.; Chiang, W.; Liu, W.J. 1989: Lymphocyte transformation in patients with HBsAg-positive chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma Journal of the Formosan Medical Association 88(6): 557-561
Sampliner, R. 1977: Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. the need for liver biopsy JAMA 237(1): 50-51
Tomás Gilabert, J.; Galán Navarro, M.I.; Caballero Morales, T.; Maroto Vela, M.C.; Ruiz Extremera, A.; Salmerón Escobar, F.J. 1991: Study of viral replication in HbsAg positive chronic hepatitis Revista Clinica Espanola 188(4): 174-177
Koziol, D.E.; Alter, H.J.; Kirchner, J.P.; Holland, P.V. 1976: The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg Journal of Immunology 117(6): 2260-2262
Borgiani, L.; Calzia, R.; Campelli, A.; Marazzi, M.G.; Piscopo, R.; Dorati, M.; Canepari, A.; Losurdo, G.; Canepa, M. 1986: Behaviour of immunohistochemically demonstrated HBV antigens in chronic HBsAg-positive hepatitis in children Pathologica 78(1057): 563-572
Pongpipat, D.; Suvatte, V.; Assateerawatts, A. 1986: Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg Asian Pacific Journal of Allergy and Immunology 4(1): 33-36
Caredda, F.; Antinori, S.; Coppin, P.; Parravicini, C.; Vago, L.; Moroni, M. 1991: The influence of human immunodeficiency virus infection on acute and chronic HBsAg-positive hepatitis Progress in Clinical and Biological Research 364: 365-375
Nassal, M.; Theilmann, L.; Pfaff, E. 1987: Rapid procedure for the detection of hepatitis delta virus RNA in sera of HBsAg-positive and anti-delta-positive patients Arzneimittel-Forschung 37(6): 748-751
Lai, M.Y.; Chen, D.S.; Lee, S.C.; Su, I.J.; Yang, P.M.; Hsu, H.C.; Sung, J.L. 1988: Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohistochemical studies Hepato-Gastroenterology 35(1): 17-21
Seetlani, N.K.; Abbas, Z.; Raza, S.; Yakoob, J.; Jafris, W. 2009: Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics JPMA. Journal of the Pakistan Medical Association 59(7): 434-437
Sotaniemi, E.A.; Hynnynen, T.; Ahlqvist, J.; Ahokas, J.T.; Puoskari, U.; Pelkonen, I. 1978: Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis Journal of Medicine 9(2): 117-128
Facciorusso, D.; Giacobbe, A. 1996: Evaluation of two treatment schedules with different doses of interferon in chronic HBsAg+ anti-HBe+ hepatitis Recenti Progressi in Medicina 87(1): 12-15
Siurin, S.A. 1997: Effects of essential oil on lipid peroxidation and lipid metabolism in patients with chronic bronchitis Klinicheskaia Meditsina 75(10): 43-45
Actis, G.C.; Maran, E.; Bonino, F.; Saracco, G.; Rosina, F.; Brunetto, M.R.; Baldi, M.; Rizzetto, M.; Verme, G.; Rocca, B. 1987: Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response Journal of Biological Regulators and Homeostatic Agents 1(1): 45-50
Françoise Lunel-Fabiani; Duburcq, X.; Levayer, T.; Descamps, F.; Michèle Maniez-Montreuil; Pivert, A.; Ducancelle, A.; Pouzet, A.; Marant, L.; Cl, A.èment; Duhamel, D.; Leirens, Y.; Margotteau, F.; Falcou, R.-Briatte; Heinen, C.; Bouniort, F.; Taskar, S.; Artus, A.; Woodrum, D.; Flecheux, O. 2010: Multi-Center Evaluation of the Hepatitis B Surface Antigen (HBsAg) Assay and HBsAg Confirmatory Assay for the Family of Access® Immunoassay Systems Clinical Laboratory 56(7-8): 281-290
Zhong, L.-H.; Jiang, Y.-M.; Lou, G.-Q.; Yu, X.-L.; Liu, H.; Guo, J.-C.; Zhu, M.-F.; Xun, Y.-H. 2013: The relationship between serum HBsAg levels and liver inflammation and fibrosis in patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 27(2): 92-94